{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T16:04:29Z","timestamp":1765728269218,"version":"3.41.2"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1023\/b:ddas.0000034562.17003.50","type":"journal-article","created":{"date-parts":[[2004,7,13]],"date-time":"2004-07-13T22:48:50Z","timestamp":1089758930000},"page":"1000-1006","source":"Crossref","is-referenced-by-count":28,"title":["Acute Pancreatitis Associated with Interferon and Ribavirin Therapy in Patients with Chronic Hepatitis C"],"prefix":"10.1007","volume":"49","author":[{"given":"Swati","family":"Chaudhari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhupinderjit S.","family":"Anand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neville R.","family":"Pimstone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas T.","family":"Dieterich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Batash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edmund J.","family":"Bini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"492761_CR1","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJM199908193410802","volume":"341","author":"MJ Alter","year":"1999","unstructured":"Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, Kaslow RA, Margolis HS: The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 341:556\u2013562, 1999","journal-title":"N Engl J Med"},{"key":"492761_CR2","doi-asserted-by":"crossref","first-page":"83S","DOI":"10.1002\/hep.510260715","volume":"26","author":"RL Carithers Jr","year":"1997","unstructured":"Carithers RL Jr, Emerson SS: Therapy of hepatitis C: meta-analysis of interferon alfa-2b trials. Hepatology 26:83S\u201388S, 1997","journal-title":"Hepatology"},{"key":"492761_CR3","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/hep.510300116","volume":"30","author":"GT Everson","year":"1999","unstructured":"Everson GT, Jensen DM, Craig JR, Van Leeuwen DJ, Bain VG, Ehrinpreis MN, Albert D, Joh T, Witt K: Efficacy of interferon treatment for patients with chronic hepatitis C: Comparison of response in cirrhotics, fibrotics, or nonfibrotics. Hepatology 30:271\u2013276, 1999","journal-title":"Hepatology"},{"key":"492761_CR4","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1053\/jhep.2001.26371","volume":"34","author":"KL Lindsay","year":"2001","unstructured":"Lindsay KL, Trepo C, Heintges T, Shiffman ML, Gordon SC, Hoefs JC, Schiff ER, Goodman ZD, Laughlin M, Yao R, Albrecht JK: A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C. Hepatology 34:395\u2013403, 2001","journal-title":"Hepatology"},{"key":"492761_CR5","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM199811193392101","volume":"339","author":"JG McHutchison","year":"1998","unstructured":"McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, Goodman ZD, Ling MH, Cort S, Albrecht JK: Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group [see comments]. N Engl J Med 339:1485\u20131492, 1998","journal-title":"N Engl J Med"},{"key":"492761_CR6","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/S0140-6736(98)07124-4","volume":"352","author":"T Poynard","year":"1998","unstructured":"Poynard T, Marcellin P, Lee SS, Niederau C, Minuk GS, Ideo G, Bain V, Heathcote J, Zeuzem S, Trepo C, Albrecht J: Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT) [see comments]. Lancet 352:1426\u20131432, 1998","journal-title":"Lancet"},{"key":"492761_CR7","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","volume":"358","author":"MP Manns","year":"2001","unstructured":"Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, Goodman ZD, Koury K, Ling M, Albrecht JK: Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomized trial. Lancet 358:958\u2013965, 2001","journal-title":"Lancet"},{"key":"492761_CR8","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","volume":"347","author":"MW Fried","year":"2002","unstructured":"Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Goncales FL Jr, Haussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J: Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 347:975\u2013982, 2002","journal-title":"N Engl J Med"},{"key":"492761_CR9","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0016-5085(03)00394-9","volume":"124","author":"MW Russo","year":"2003","unstructured":"Russo MW, Fried MW: Side effects of therapy for chronic hepatitis C. Gastroenterology 124:1711\u20131719, 2003","journal-title":"Gastroenterology"},{"key":"492761_CR10","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1046\/j.1365-2036.2002.01331.x","volume":"16","author":"GB Gaeta","year":"2002","unstructured":"Gaeta GB, Precone DF, Felaco FM, Bruno R, Spadaro A, Stornaiuolo G, Stanzione M, Ascione T, De Sena R, Campanone A, Filice G, Piccinino F: Premature discontinuation of interferon plus ribavirin for adverse effects: A multicentre survey in \u2018real world\u2019 patients with chronic hepatitis C. Aliment Pharmacol Ther 16:1633\u20131639, 2002","journal-title":"Aliment Pharmacol Ther"},{"key":"492761_CR11","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1053\/gast.2000.8528","volume":"119","author":"IA Eland","year":"2000","unstructured":"Eland IA, Rasch MC, Sturkenboom MJ, Bekkering FC, Brouwer JT, Delwaide J, Belaiche J, Houbiers G, Stricker BH: Acute pancreatitis attributed to the use of interferon alfa-2b. Gastroenterology 119:230\u2013233, 2000","journal-title":"Gastroenterology"},{"key":"492761_CR12","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJM199404283301706","volume":"330","author":"W Steinberg","year":"1994","unstructured":"Steinberg W, Tenner S: Acute pancreatitis. N Engl J Med 330:1198\u20131210, 1994","journal-title":"N Engl J Med"},{"key":"492761_CR13","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/bjs.4179","volume":"90","author":"M Yousaf","year":"2003","unstructured":"Yousaf M, McCallion K, Diamond T: Management of severe acute pancreatitis. Br J Surg 90:407\u2013420, 2003","journal-title":"Br J Surg"},{"key":"492761_CR14","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0016-5085(80)90689-7","volume":"78","author":"A Mallory","year":"1980","unstructured":"Mallory A, Kern F Jr: Drug-induced pancreatitis: A critical review. Gastroenterology 78:813\u2013820, 1980","journal-title":"Gastroenterology"},{"key":"492761_CR15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2036.1996.tb00174.x","volume":"10","author":"KE McArthur","year":"1996","unstructured":"McArthur KE: Review article: Drug-induced pancreatitis. Aliment Pharmacol Ther 10:23\u201338, 1996","journal-title":"Aliment Pharmacol Ther"},{"key":"492761_CR16","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/ajh.2830480321","volume":"48","author":"M Sotomatsu","year":"1995","unstructured":"Sotomatsu M, Shimoda M, Ogawa C, Morikawa A: Acute pancreatitis associated with interferon-alpha therapy for chronic myelogenous leukemia. Am J Hematol 48:211\u2013212, 1995","journal-title":"Am J Hematol"},{"key":"492761_CR17","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3109\/10428190009113396","volume":"39","author":"NM Tannir","year":"2000","unstructured":"Tannir NM, Talpaz M, Ghazal H, Proothi S, Kantarjian HM: Acute pancreatitis associated with interferon alpha therapy for chronic myelogenous leukemia. Leuk Lymphoma 39:647\u2013650, 2000","journal-title":"Leuk Lymphoma"},{"key":"492761_CR18","doi-asserted-by":"crossref","first-page":"897","DOI":"10.7326\/0003-4819-123-12-199512150-00001","volume":"123","author":"AM Di Bisceglie","year":"1995","unstructured":"Di Bisceglie AM, Conjeevaram HS, Fried MW, Sallie R, Park Y, Yurdaydin C, Swain M, Kleiner DE, Mahaney K, Hoofnagle JH: Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 123:897\u2013903, 1995","journal-title":"Ann Intern Med"},{"key":"492761_CR19","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0168-8278(96)80225-X","volume":"25","author":"G Dusheiko","year":"1996","unstructured":"Dusheiko G, Main J, Thomas H, Reichard O, Lee C, Dhillon A, Rassam S, Fryden A, Reesink H, Bassendine M, Norkrans G, Cuypers T, Lelie N, Telfer P, Watson J, Weegink C, Sillikens P, Weiland O: Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study. J Hepatol 25:591\u2013598, 1996","journal-title":"J Hepatol"},{"key":"492761_CR20","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2893.1996.tb00050.x","volume":"3","author":"JH Hoofnagle","year":"1996","unstructured":"Hoofnagle JH, Lau D, Conjeevaram H, Kleiner D, Di Bisceglie AM: Prolonged therapy of chronic hepatitis Cwith ribavirin. J Viral Hepat 3:247\u2013252, 1996","journal-title":"J Viral Hepat"},{"key":"492761_CR21","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/hep.510260231","volume":"26","author":"J. Bodenheimer HC","year":"1997","unstructured":"Bodenheimer HC Jr, Lindsay KL, Davis GL, Lewis JH, Thung SN, Seeff LB: Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: a multicenter trial. Hepatology 26:473\u2013477, 1997","journal-title":"Hepatology"},{"key":"492761_CR22","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/135965359900400404","volume":"4","author":"LE Chapman","year":"1999","unstructured":"Chapman LE, Mertz GJ, Peters CJ, Jolson HM, Khan AS, Ksiazek TG, Koster FT, Baum KF, Rollin PE, Pavia AT, Holman RC, Christenson JC, Rubin PJ, Behrman RE, Bell LJ, Simpson GL, Sadek RF: Intravenous ribavirin for hantavirus pulmonary syndrome: Safety and tolerance during 1 year of open-label experience. Ribavirin Study Group. Antivir Ther 4:211\u2013219, 1999","journal-title":"Antivir Ther"},{"key":"492761_CR23","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1111\/j.1572-0241.1998.00546.x","volume":"93","author":"C Fernandez-Miranda","year":"1998","unstructured":"Fernandez-Miranda C, Castellano G, Guijarro C, Fernandez I, Schoebel N, Larumbe S, Gomez-Izquierdo T, del Palacio A: Lipoprotein changes in patients with chronic hepatitis C treated with interferon-alpha. Am J Gastroenterol 93:1901\u20131904, 1998","journal-title":"Am J Gastroenterol"},{"key":"492761_CR24","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1111\/j.1572-0241.2001.04055.x","volume":"96","author":"M Naeem","year":"2001","unstructured":"Naeem M, Bacon BR, Mistry B, Britton RS, Di Bisceglie AM: Changes in serum lipoprotein profile during interferon therapy in chronic hepatitis C. Am J Gastroenterol 96:2468\u20132472, 2001","journal-title":"Am J Gastroenterol"},{"key":"492761_CR25","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/hep.510250632","volume":"25","author":"E Shinohara","year":"1997","unstructured":"Shinohara E, Yamashita S, Kihara S, Hirano K, Ishigami M, Arai T, Nozaki S, Kameda-Takemura K, Kawata S, Matsuzawa Y: Interferon alpha induces disorder of lipid metabolism by lowering postheparin lipases and cholesteryl ester transfer protein activities in patients with chronic hepatitis C. Hepatology 25:1502\u20131506, 1997","journal-title":"Hepatology"},{"key":"492761_CR26","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1517\/14656566.2.8.1317","volume":"2","author":"NJ Snell","year":"2001","unstructured":"Snell NJ: Ribavirin\u2014Current status of a broad spectrum antiviral agent. Expert Opin Pharmacother 2:1317\u20131324, 2001","journal-title":"Expert Opin Pharmacother"},{"key":"492761_CR27","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1023\/A:1010618627594","volume":"46","author":"G Lake-Bakaar","year":"2001","unstructured":"Lake-Bakaar G, Mazzoccoli V, Dickman K, Lyubsky S: Differential effects of nucleoside analogs on oxidative phosphorylation in human pancreatic cells. Dig Dis Sci 46:1853\u20131863, 2001","journal-title":"Dig Dis Sci"},{"key":"492761_CR28","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJM199510263331702","volume":"333","author":"R McKenzie","year":"1995","unstructured":"McKenzie R, Fried MW, Sallie R, Conjeevaram H, Di Bisceglie AM, Park Y, Savarese B, Kleiner D, Tsokos M, Luciano C: Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. N Engl J Med 333:1099\u20131105, 1995","journal-title":"N Engl J Med"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/B:DDAS.0000034562.17003.50.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/B:DDAS.0000034562.17003.50\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/B:DDAS.0000034562.17003.50.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T03:41:24Z","timestamp":1753760484000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/B:DDAS.0000034562.17003.50"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["492761"],"URL":"https:\/\/doi.org\/10.1023\/b:ddas.0000034562.17003.50","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"type":"print","value":"0163-2116"},{"type":"electronic","value":"1573-2568"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}